Skip to main content

and
  1. Article

    Open Access

    NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

    Analysis of selected cancer genes has become an important tool in precision oncology but cannot fully capture the molecular features and, most importantly, vulnerabilities of individual tumors. Observational a...

    Andreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt in npj Precision Oncology (2023)

  2. Article

    Open Access

    Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

    The benefit of molecularly-informed therapies in cancer of unknown primary (CUP) is unclear. Here, we use comprehensive molecular characterization by whole genome/exome, transcriptome and methylome analysis in...

    Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Mock in Nature Communications (2022)

  3. Article

    Open Access

    The landscape of chromothripsis across adult cancer types

    Chromothripsis is a recently identified mutational phenomenon, by which a presumably single catastrophic event generates extensive genomic rearrangements of one or a few chromosome(s). Considered as an early e...

    Natalia Voronina, John K. L. Wong, Daniel Hübschmann in Nature Communications (2020)

  4. No Access

    Article

    Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains

    Fusion proteins involving the BRAF serine/threonine kinase occur in many cancers. The oncogenic potential of BRAF fusions has been attributed to the loss of critical N-terminal domains that mediate BRAF autoin...

    Florian Weinberg, Ricarda Griffin, Martina Fröhlich, Christoph Heining in Oncogene (2020)

  5. Article

    Open Access

    Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

    Chordomas are rare bone tumors with few therapeutic options. Here we show, using whole-exome and genome sequencing within a precision oncology program, that advanced chordomas (n = 11) may be characterized by gen...

    Stefan Gröschel, Daniel Hübschmann, Francesco Raimondi in Nature Communications (2019)

  6. Article

    Open Access

    From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

    A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hind...

    Júlia Perera-Bel, Barbara Hutter, Christoph Heining, Annalen Bleckmann in Genome Medicine (2018)

  7. Article

    Open Access

    STSE: Spatio-Temporal Simulation Environment Dedicated to Biology

    Recently, the availability of high-resolution microscopy together with the advancements in the development of biomarkers as reporters of biomolecular interactions increased the importance of imaging methods in...

    Szymon Stoma, Martina Fröhlich, Susanne Gerber, Edda Klipp in BMC Bioinformatics (2011)